Gnosis Wins Product Development Strategy Award

DESIO, ItalyGnosis won the Nutraceutical Business & Technology (NBT)  award for Most Effective Product Development Strategy" with Mythocondro®, the first non-animal chondroitin sulfate (CS).

The company developed Mythocondro® through an innovative fermentation technology to resolve the problems of poor quality and potential safety issues of animal-derived CS. Mythocondro® presents a reliable solution to the population's demand for effective bone health improvement products with its high purity and low protein content.

In 2011, Gnosis won the same award for its development of the folate derivative Quatrefolic®.

For information on nutrients for bone health, read the INSIDER feature "Bone, Joint Ingredients Find Synergistic Strength."